87 related articles for article (PubMed ID: 396401)
1. [Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)].
Ueda Y; Tojo S; Hatano M; Furukawa T; Yoshinaga K; Kinoshita Y; Takeuchi J; Kato E; Ohno J; Kobayashi K; Abe H; Omae S
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1171-83. PubMed ID: 396401
[No Abstract] [Full Text] [Related]
2. [The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)].
Ishikawa H; Honjo A; Hayashi M; Hamaguchi T; Morita T; Tesutani T; Yamamoto M; Fujimoto Y; Okubo A; Oka G
Nihon Jinzo Gakkai Shi; 1979 Feb; 21(2):135-55. PubMed ID: 381736
[No Abstract] [Full Text] [Related]
3. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
Ishikawa H; Honjo A; Hayashi M; Hamaguchi T; Morita T; Shindo T; Tetsutani T; Yamamoto T; Okubo H; Oka G
Arzneimittelforschung; 1982; 32(3):301-9. PubMed ID: 7200790
[No Abstract] [Full Text] [Related]
4. [Dipyridamole therapy in the nephrotic syndrome (author's transl)].
Tojo S; Narita M; Suzuki H; Sano M; Koyama A; Tsuchiya T; Yamamoto S; Tsuchida H; Shishido H; Watanabe K
Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):255-66. PubMed ID: 671851
[No Abstract] [Full Text] [Related]
5. Dipyridamole therapy in the nephrotic syndrome.
Tojo S; Narita M; Koyama A; Sano M; Suzuki H; Tsuchiya T; Tsuchida H; Yamamoto S; Shishido H
Contrib Nephrol; 1978; 9():111-27. PubMed ID: 352614
[TBL] [Abstract][Full Text] [Related]
6. Effect of dipyridamole on proteinuria of nephrotic syndrome.
Okada S; Kurata N; Ota Z; Ofuji T
Lancet; 1981 Mar; 1(8222):719-20. PubMed ID: 6110931
[No Abstract] [Full Text] [Related]
7. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
van der Meer J; Wouda AA; Kallenberg CG; Wesseling H
Vasa Suppl; 1987; 18():71-5. PubMed ID: 3299819
[No Abstract] [Full Text] [Related]
8. A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
Statham B; Finlay AY; Marks R
Acta Derm Venereol; 1981; 61(3):270-1. PubMed ID: 6167117
[TBL] [Abstract][Full Text] [Related]
9. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
Ciavarella N; Antoncecchi S; D'Elia N
Cardiologia; 1985 Apr; 30(4):301-7. PubMed ID: 3914360
[No Abstract] [Full Text] [Related]
10. Treatment of claudication with dipyridamole and aspirin.
Libretti A; Catalano M
Int J Clin Pharmacol Res; 1986; 6(1):59-60. PubMed ID: 3514494
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis.
Can Med Assoc J; 1976 Dec; 115(12):1209-10. PubMed ID: 793706
[TBL] [Abstract][Full Text] [Related]
12. [Alteration of selectivity in proteinuria through relapse of steroid sensitive nephrosis in childhood (author's transl)].
Rossipal E
Padiatr Padol; 1971; 6(4):365-70. PubMed ID: 5164152
[No Abstract] [Full Text] [Related]
13. [Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. I. General protocol. From the DAMAD Study Group (author's transl)].
Diabete Metab; 1982 Jun; 8(2):91-6. PubMed ID: 7049782
[TBL] [Abstract][Full Text] [Related]
14. [Cell-mediated immunity and effects of cyclophosphamide on primary nephrotic syndrome (author's transl)].
Okura T; Matsuo S; Kumon S; Hibi I; Tamaki S; Watanabe Y; Kinoshita Y
Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1395-403. PubMed ID: 7334719
[No Abstract] [Full Text] [Related]
15. Selectivity of proteinuria in nephrotic syndrome.
Tay CH; Chen TM; Wee R
Singapore Med J; 1971 Aug; 12(4):233-6. PubMed ID: 5002036
[No Abstract] [Full Text] [Related]
16. Dipyridamole - is it a bronchodilator?
Ruffin RE; Newhouse MT
Eur J Respir Dis; 1981; 62(2):123-6. PubMed ID: 7016567
[No Abstract] [Full Text] [Related]
17. Mechanisms of steroid-enhanced proteinuria in nephrotic patients.
Kumagai H; Hishida A; Nagase M; Honda N
Nihon Jinzo Gakkai Shi; 1987 Mar; 29(3):277-81. PubMed ID: 3613255
[No Abstract] [Full Text] [Related]
18. [Effects of corticosteroid and indomethacin treatment on proteinuria].
Michielsen P; Lambert PP
Bull Mem Soc Med Hop Paris; 1967 Feb; 118(3):217-32. PubMed ID: 6058837
[No Abstract] [Full Text] [Related]
19. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Hopper AH; Tindall H; Davies JA
Nephrol Dial Transplant; 1989; 4(2):140-3. PubMed ID: 2496357
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antiplatelet agents, dipyridamole and dilazep dihydrochloride, on in vivo platelet function and proteinuria.
Inage H; Koyama A; Narita M; Tojo S
Nihon Jinzo Gakkai Shi; 1985 Sep; 27(9):1261-70. PubMed ID: 4087547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
